Nuclear import and DNA binding of human papillomavirus type 45 L1 capsid protein

被引:0
|
作者
Nelson, LM
Rose, RC
LeRoux, L
Lane, C
Bruya, K
Moroianu, J
机构
[1] Boston Coll, Dept Biol, Cell Biol Lab, Chestnut Hill, MA 02467 USA
[2] Univ Rochester, Sch Med & Dent, Dept Med Microbiol & Immunol, Infect Dis Unit, Rochester, NY 14642 USA
关键词
DNA binding; HPV45; L1 capsid protein; nuclear import;
D O I
10.1002/1097-4644(20001101)79:2<225::AID-JCB60>3.3.CO;2-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the life cycle of human papillomaviruses (HPVs), the L1 capsid proteins seem to enter the nucleus twice: once after the virions infect the cells, and later during the productive phase when they assemble the replicated HPV genomic DNA into infectious virions. We established for the high-risk HPV45 that when digitonin-permeabilized HeLa cells were incubated with L1 homopentameric capsomers, the HPV45 L1 protein was imported into the nucleus in a receptor-mediated manner. In contrast, intact capsids were not able to enter the nucleus. Immunoisolation assays showed that HPV45 L1 capsomers interact with cytosolic karyopherin alpha 2 beta 1 heterodimers. HPV45 L1 bound strongly to karyopherin alpha 2, and weakly to karyopherin beta 1, as did its nuclear localization signal (NLS). Nuclear import of HPV45 L1, or of a GST-NLSHPV45L1 fusion protein was efficiently mediated by karyopherin alpha 2 beta 1 heterodimers, and only weakly by karyopherin beta 1. Nuclear import required RanGDP, but was independent of GTP hydrolysis by Ran. Together, these data suggest that the major nuclear import pathway for HPV45 L1 major capsid protein in infected host cells is mediated by karyopherin alpha 2 beta 1 heterodimers and that GTP hydrolysis by Ran is not required for import. Remarkably, HPV45 L1 capsomers can interact nonspecifically with different types of HPV-DNA, and the DNA binding region of HPV45 L1 overlaps with its NLS sequence. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:225 / 238
页数:14
相关论文
共 50 条
  • [31] Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus type 16 pseudovirions by binding to cysteine residues of major capsid protein L1
    Ishii, Yoshiyuki
    Kondo, Kazunari
    Matsumoto, Tamae
    Tanaka, Keiko
    Shinkai-Ouchi, Fumiko
    Hagiwara, Ken'ichi
    Kanda, Tadahito
    VIROLOGY JOURNAL, 2007, 4 (1)
  • [32] Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus type 16 pseudovirions by binding to cysteine residues of major capsid protein L1
    Yoshiyuki Ishii
    Kazunari Kondo
    Tamae Matsumoto
    Keiko Tanaka
    Fumiko Shinkai-Ouchi
    Ken'ichi Hagiwara
    Tadahito Kanda
    Virology Journal, 4
  • [33] Synthesis of viral DNA and late capsid protein L1 in parabasal spinous cell layers of naturally occurring benign warts infected with human papillomavirus type 1
    Egawa, K
    Iftner, A
    Doorbar, J
    Honda, Y
    Iftner, T
    VIROLOGY, 2000, 268 (02) : 281 - 293
  • [34] HPV L1 CAPSID PROTEIN DETECTION IN HIGH RISK HUMAN PAPILLOMAVIRUS POSITIVE CERVICAL SMEARS
    Horton, A.
    Heunis, N.
    Richter, K. L.
    Dreyer, G.
    Louw, M.
    ACTA CYTOLOGICA, 2010, 54 (03) : 394 - 395
  • [35] A human papillomavirus type 16 vaccine by oral delivery of L1 protein
    Sasagawa, T
    Tani, M
    Basha, W
    Rose, RC
    Tohda, H
    Giga-Hama, Y
    Azar, KK
    Yasuda, H
    Sakai, A
    Inoue, M
    VIRUS RESEARCH, 2005, 110 (1-2) : 81 - 90
  • [36] Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein
    Dolei, A
    Curreli, S
    Marongiu, P
    Pierangeli, A
    Gomes, E
    Bucci, M
    Serra, C
    Degener, AM
    JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 2937 - 2944
  • [37] Enhancement of capsid gene expression:: Preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes
    Leder, C
    Kleinschmidt, JA
    Wiethe, C
    Müller, M
    JOURNAL OF VIROLOGY, 2001, 75 (19) : 9201 - 9209
  • [38] Human papillomavirus type 16 and 18 L1 protein peptide binding to vero and hela cells inhibits their VLPS binding
    Vera-Bravo, R
    Ocampo, M
    Urquiza, M
    García, JE
    Rodríguez, LE
    Puentes, A
    López, R
    Curtidor, H
    Suárez, JE
    Torres, E
    Guzmán, F
    Díaz, D
    Cortes, J
    Bravo, MM
    Cómbita, AL
    Orozco, O
    Patarroyo, ME
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (03) : 416 - 424
  • [39] Human papillomavirus DNA, HPV L1 capsid protein and p16INK4a protein as markers to predict cervical lesion progression
    Huiyan Hu
    Jingjing Zhao
    Wen Yu
    Junwei Zhao
    Zhewei Wang
    Lin Jin
    Yunyun Yu
    Lingfei Han
    Lu Wang
    Huiting Zhu
    Fang Li
    Archives of Gynecology and Obstetrics, 2019, 299 : 141 - 149
  • [40] Protective cell-mediated immunity by DNA vaccination against papillomavirus L1 capsid protein in the cottontail rabbit papillomavirus model
    Hu, Jiafen
    Cladel, Nancy M.
    Budgeon, Lynn R.
    Reed, Cynthia A.
    Pickel, Martin D.
    Christensen, Neil D.
    VIRAL IMMUNOLOGY, 2006, 19 (03) : 492 - 507